CSBR241220P10000
- 0.00
- 0.000.00%
Champions Oncology Newsroom
Further Upside For Champions Oncology, Inc. (NASDAQ:CSBR) Shares Could Introduce Price Risks After 38% Bounce
Craig-Hallum Maintains Buy on Champions Oncology, Raises Price Target to $8
Champions Oncology Analyst Ratings
Express News | Champions Oncology Inc : Craig-Hallum Raises Target Price to $8 From $6
Stocks to Watch: Adobe, Champions Oncology, DBV Technologies
Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript
Express News | Champions Oncology Shares Are Trading Higher After the Company Reported a Year-over-year Increase in Q2 Financial Results
Earnings Flash (CSBR) CHAMPIONS ONCOLOGY Reports Q2 EPS $0.05, Vs. Street Est of $0.01
Express News | Champions Oncology Q2 Revenue USD 13.5 Million
Express News | Champions Oncology Q2 Adjusted Ebitda USD 1.1 Million
Express News | Champions Oncology Q2 EPS USD 0.05
Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million
Earnings Scheduled For December 11, 2024
A Peek at Champions Oncology's Future Earnings
Craig-Hallum Maintains Champions Oncology(CSBR.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Inotiv (NOTV), Ascendis Pharma (ASND) and Champions Oncology (CSBR)
Champions oncology (CSBR.US) will release its financial report after the market closes on December 11.
$Champions Oncology(CSBR.US)$ will release its financial report after the market closes on December 11, and investors are advised to pay attention. How was the performance previously? $Champions Oncology(CSBR.US)$ reported revenue of 14.061 million USD and net income of 1.313 million USD with an eps of 0.09 USD for Q1 2025. For Q2 2024, revenue was 11.573 million USD, net income was -2.071 million USD, and eps was -0.15 USD. The accounting standards used for the above data are US_.
Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024
Champions Oncology (NASDAQ:CSBR) Shareholders Have Endured a 61% Loss From Investing in the Stock Three Years Ago
Champions Oncology Announces Agreement With Weill Cornell Medicine